Search Results for "Precision Medicine"
Genetic testing to guide antidepressant choices: Big news coverage, but limited evidence
The evidence cited here is still very preliminary, a finding we also noticed in another recently reviewed article on using genetic testing for targeting depression meds.
Which antidepressant is right for you? This genetic test could help
Pathologists predicted the Theranos debacle, but their voices were missing from most news coverage
Theranos, the fraudulent laboratory company whose rise and fall is recounted in a recent exposé entitled “Bad Blood,” was a darling of investors and news outlets for a more than a decade. The company suffered a rapid change of fate in late 2015 after Wall Street Journal reporter John Carreyrou revealed the shaky underpinnings of […]
Gene test for depression treatment: Realistic patient story helps keep WSJ article grounded
But the story did not do enough to establish that the research is still preliminary — it has not been published nor peer-reviewed, and everyone is relying on just a little bit of data released by the company.
Which Anti-Depressant is Right for You? Your DNA Can Shed Some Light
Podcast: Gut Punch – Marketing Microbiome Hype
Our microbiome. We’re told it may hold the key to better understanding and treating a host of diseases. But the supporting research isn’t even close to that point. Nonetheless, the media continues to hype the microbiome and that has consequences.
Marketing misfire on ‘spa-like’ 3D mammograms: Comfort appeal distracts from real concerns on screening, experts say
There’s a reason mammograms are the perfect fodder for female comedians. There is little merriment in having your breast manipulated onto a table and then squeezed between square metal plates. But it does make for a good joke. That 30-second window of discomfort is also a great marketing opportunity. Over the past few months we’ve […]
5-Star Friday: Tackling the unwieldy
Many of the health care journalists we review are brave, intrepid, or both. Health care is not an easy beat. It’s quite a mash-up of science, politics, economics, ethics, law, technology and … well … us. These are big topics. A bit unwieldy. The writers featured in this week’s 5-Star Friday have taken on some […]5
Mayo Clinic woos reporters with fellowship offer
The Mayo Clinic is deploying a new tactic to influence journalists: An all-expenses-paid residency program. Last week the health system invited reporters to apply for a five-day fellowship at its Rochester, Minn., campus entitled “Mayo Foundation Journalist Residency: Behind the Scenes in Surgery.” Mayo described the program as “an in-depth look at the latest developments in […]
The trail of tainted funding: Conflicts of interest in healthcare, academics, public relations and journalism
Healthcare is big business, and conflicts of interest are pervasive. Who stands to gain what is always an important question to ask–whether you’re a journalist or a healthcare consumer. But as we’ve found, many financial relationships are obscured or not ever reported, so it can be very hard to answer that question. We’ve written a number […]
For story on experimental prostate cancer blood test, Guardian leans heavily on news release
Unfortunately, this article glosses over the measured benefits, the costs, the harms–and much more.
Prostate cancer blood test could transform treatment, say scientists
Small studies get big headlines at ASCO 2017
Nearly 40,000 cancer specialists have converged in Chicago for the world’s largest cancer meeting. The American Society of Clinical Oncology (ASCO) meeting — which began last Friday and runs through tomorrow — traditionally draws international media attention. As our deputy managing editor, Joy Victory, reported last week, it has become a perennial exercise in spotting […]1
6 things to keep in mind if you read cancer-related news in the next few days
Today kicks off the annual meeting of the American Society of Clinical Oncology, the world’s largest cancer research conference, which is taking place in Chicago and runs through Monday. In the next few days, if you read any news stories about cancer treatment, there’s a good chance those stories originated at ASCO’s meeting. The media […]4
As health care costs spiral higher, hospital price increases are flying under the radar
Let’s face it. The U.S is not coming to grips with the high cost of medical care anytime soon. The media’s fling with high drug prices is about over. Mylan now sells a generic version of the EpiPen — $300 for two doses instead of $600 — low enough to smother the fires of outrage […]4
How much significance should health news give to statistically nonsignificant results? A case study of stories on skipping breast cancer chemo
Kevin Lomangino is the managing editor of HealthNewsReview.org. He tweets as @KLomangino. The big story on our health news radar yesterday was about a gene test that identifies women with early-stage breast cancer who may be able to safely skip chemotherapy. In a large randomized study published in the New England Journal of Medicine, women who […]
Contrary to PR release claim, it’s too early to call asthma pill a “game changer”
This study of a new potential asthma treatment involved just 61 patients and lasted 12 weeks. The results may show promise but it will be years before the asthma pill reaches patients — if ever.
Asthma pill could reduce symptoms in severe sufferers
Stanford group offers prize for healthcare social media research ideas
The following is a guest blog post from one of our contributors, Sally James of Seattle, an active observer of, and participant in, health/medicine/science-related social media. She tweets as @jamesian. People learn about healthcare from many places: their local hair salon, People magazine, newspapers, Google and their friends. Here at HealthNewsReview.org, our daily work is […]